SFOSF
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF), founded in 1994 and based in Shanghai, China, is a comprehensive pharmaceutical enterprise. The company is actively engaged in the research, development, manufacturing, and sale of pharmaceutical products, serving markets across Mainland China and internationally. Its diverse operations are structured into five main segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Services, Pharmaceutical Distribution and Retail, and Other Business activities. Within its pharmaceutical portfolio, Fosun Pharma focuses on critical therapeutic areas such as oncology, immune system modulation, metabolic disorders, gastrointestinal conditions, and central nervous system ailments. Beyond its drug offerings, the company also provides a range of medical equipment and diagnostic solutions. Furthermore, SFOSF is involved in delivering healthcare services and managing hospitals, alongside its wholesale and retail distribution of medicines.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 0.33 | $10.1B | $57M |
| 2025 Q4 | 0.62 | $21.7B | $552M |
| 2025 Q2 | 0.35 | $10.1B | $123M |
| 2025 Q1 | 0.29 | $9.4B | -$63M |
| 2024 Q4 | 0.29 | $10.2B | $107M |
| 2024 Q3 | 0.30 | $10.4B | $146M |
| 2024 Q2 | 0.23 | $10.2B | $248M |
| 2024 Q1 | 0.23 | $10.1B | -$199M |